No Data
No Data
Express News | Syndax Pharmaceuticals Reports Inducement Grants Under Nasdaq Listing Rule 5635(C)(4)
Syndax Pharmaceuticals Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)
Syndax Announces Participation in November Investor Conferences
Watching Syndax Pharmaceuticals; Traders Circulate Ray Blanco Mentions Stock As A Pick On Investors Newsletter
Earnings Preview: SNDX to Report Financial Results Post-market on November 05
Syndax to Announce Third Quarter 2024 Financial Results and Host Conference Call and Webcast on November 5, 2024
No Data
No Data